Skip to main content
BOSTON SCIENTIFIC CORP logo

BOSTON SCIENTIFIC CORP — Investor Relations & Filings

Ticker · BSX ISIN · US1011371077 LEI · Y6ZDD9FP4P8JSSJMW954 US Manufacturing
Filings indexed 3,157 across all filing types
Latest filing 2022-12-14 Director's Dealing
Country US United States of America
Listing US BSX

About BOSTON SCIENTIFIC CORP

https://www.bostonscientific.com/en-US/…

Boston Scientific Corporation is a global medical technology company that develops, manufactures, and commercializes a broad range of high-performance medical devices. The company's products are used in various minimally invasive, interventional medical specialties, including cardiology, endoscopy, neuromodulation, urology, and pelvic health. Focused on transforming lives through innovative solutions, Boston Scientific is dedicated to improving the health of patients worldwide by addressing complex healthcare challenges and enhancing clinical outcomes.

Recent filings

Filing Released Lang Actions
Director's Dealing 2022
Director's Dealing
2022-12-14 English
Director's Dealing 2022
Director's Dealing
2022-12-13 English
Director's Dealing 2022
Director's Dealing
2022-12-12 English
Director's Dealing 2022
Director's Dealing
2022-12-05 English
Director's Dealing 2022
Director's Dealing
2022-11-30 English
8-K
Remuneration Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content focuses on the approval and description of the 2023 Annual Bonus Plan and two performance share programs by the Board of Directors. It includes details about executive compensation plans and related policies. There are no financial statements or quarterly/yearly financial results presented, so it is not an Annual Report (10-K) or Interim Report (IR). The document announces changes related to executive compensation plans, which falls under Remuneration Information. The presence of detailed descriptions of bonus plans and performance share programs aligns with the Remuneration Information category (DEF 14A). The document is not a proxy statement but a current report focusing on compensation plans. Therefore, the best classification is Remuneration Information (DEF 14A). The document length and detail support a high confidence score.
2022-11-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.